600267 海正药业
已收盘 09-07 15:00:00
资讯
新帖
简况
每周股票复盘：海正药业（600267）拟修订章程增高级副总裁职数
证券之星 · 09-06 02:11
每周股票复盘：海正药业（600267）拟修订章程增高级副总裁职数
股市必读：海正药业新发布《浙江海正药业股份有限公司2026年第三次临时股东会资料》
证券之星 · 09-04
股市必读：海正药业新发布《浙江海正药业股份有限公司2026年第三次临时股东会资料》
每周股票复盘：海正药业（600267）Q2净利增167.81%
证券之星 · 08-30
每周股票复盘：海正药业（600267）Q2净利增167.81%
图解海正药业中报：第二季度单季净利润同比增长167.81%
证券之星 · 08-26
图解海正药业中报：第二季度单季净利润同比增长167.81%
海正药业：公司将于9月3日召开2026年半年度业绩说明会
证券日报 · 08-25
海正药业：公司将于9月3日召开2026年半年度业绩说明会
海正药业：上半年净利润同比增长112.82%
格隆汇 · 08-25
海正药业：上半年净利润同比增长112.82%
8月24日海正药业跌7.80%，大成丰享回报混合A基金重仓该股
证券之星 · 08-24
8月24日海正药业跌7.80%，大成丰享回报混合A基金重仓该股
每周股票复盘：海正药业（600267）担保逾期已解除
证券之星 · 08-23
每周股票复盘：海正药业（600267）担保逾期已解除
8月21日海正药业跌6.70%，大成丰享回报混合A基金重仓该股
证券之星 · 08-21
8月21日海正药业跌6.70%，大成丰享回报混合A基金重仓该股
异动快报：海正药业（600267）8月10日9点41分触及涨停板
证券之星 · 08-10
异动快报：海正药业（600267）8月10日9点41分触及涨停板
每周股票复盘：海正药业（600267）5产品拟中选集采
证券之星 · 08-09
每周股票复盘：海正药业（600267）5产品拟中选集采
8月7日海正药业涨9.98%，大成丰享回报混合A基金重仓该股
证券之星 · 08-07
8月7日海正药业涨9.98%，大成丰享回报混合A基金重仓该股
8月4日海正药业涨6.39%，大成丰享回报混合A基金重仓该股
证券之星 · 08-04
8月4日海正药业涨6.39%，大成丰享回报混合A基金重仓该股
海正药业(600267.SH):他克莫司胶囊等5个产品拟中选集中带量采购
智通财经 · 08-03
海正药业(600267.SH):他克莫司胶囊等5个产品拟中选集中带量采购
海正药业(600267.SH)子公司制剂产品磷酸氟达拉滨注射液获得美国FDA批准
智通财经 · 07-24
海正药业(600267.SH)子公司制剂产品磷酸氟达拉滨注射液获得美国FDA批准
海正药业：三箭齐发+战略瘦身，老牌药企重塑增长内核
中金财经 · 07-21
海正药业：三箭齐发+战略瘦身，老牌药企重塑增长内核
海正药业（600267）披露与艾缇亚签署产品独家授权许可及合作协议，7月20日股价上涨9.98%
证券之星 · 07-20
海正药业（600267）披露与艾缇亚签署产品独家授权许可及合作协议，7月20日股价上涨9.98%
海正药业与艾缇亚达成合作
格隆汇 · 07-20
海正药业与艾缇亚达成合作
异动快报：海正药业（600267）7月20日9点53分触及涨停板
证券之星 · 07-20
异动快报：海正药业（600267）7月20日9点53分触及涨停板
每周股票复盘：海正药业（600267）获来特莫韦片注册证
证券之星 · 07-19
每周股票复盘：海正药业（600267）获来特莫韦片注册证
加载更多
公司概况
公司名称：
浙江海正药业股份有限公司
所属行业：
医药制造业
上市日期：
2000-07-25
主营业务：
浙江海正药业股份有限公司的主营业务是药品的研发、生产和销售。公司的主要产品是海博麦布片（赛斯美）、注射用哌拉西林钠他唑巴坦钠（特治星）、盐酸米诺环素胶囊（玫满）、茚达特罗格隆溴铵吸入粉雾剂（杰润）、注射用丝裂霉素、瑞舒伐他汀钙片（海舒严）、注射用亚胺培南西司他丁钠（俊特）、米尔贝肟吡喹酮片（海乐妙）、丁二磺酸腺苷蛋氨酸肠溶片（喜美欣）、英夫马芬净。
发行价格：
11.83
{"stockData":{"symbol":"600267","market":"SH","secType":"STK","nameCN":"海正药业","latestPrice":11.61,"timestamp":1788764400000,"preClose":11.64,"halted":0,"volume":14799500,"delay":0,"changeRate":-0.0026,"floatShares":1180000000,"shares":1180000000,"eps":0.744,"marketStatus":"已收盘","change":-0.03,"latestTime":"09-07 15:00:00","open":11.6,"high":11.67,"low":11.57,"amount":172000000,"amplitude":0.0086,"askPrice":11.62,"askSize":168,"bidPrice":11.61,"bidSize":979,"shortable":0,"etf":0,"ttmEps":0.744,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1788831000000},"marketStatusCode":5,"adr":0,"adjPreClose":11.64,"symbolType":"stock","openAndCloseTimeList":[[1788744600000,1788751800000],[1788757200000,1788764400000]],"highLimit":12.8,"lowLimit":10.48,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":1180272096,"isCdr":false,"pbRate":1.52,"roa":"--","peRate":15.604839,"roe":"7.2%","epsLYR":0.46,"committee":0.14547,"marketValue":13703000000,"turnoverRate":0.0125,"status":1,"floatMarketCap":13703000000},"requestUrl":"/m/hq/s/600267","defaultTab":"news","newsList":[{"id":"2665365452","title":"每周股票复盘：海正药业（600267）拟修订章程增高级副总裁职数","url":"https://stock-news.laohu8.com/highlight/detail?id=2665365452","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665365452?lang=zh_cn&edition=full","pubTime":"2026-09-06 02:11","pubTimestamp":1788631869,"startTime":"0","endTime":"0","summary":"截至2026年9月4日收盘，海正药业报收于11.64元，较上周的12.2元下跌4.59%。公司公告汇总：2026年第三次临时股东会将于9月10日召开，审议修订公司章程议案。公司公告汇总浙江海正药业股份有限公司拟修订《公司章程》部分条款，将公司高级副总裁职数由1至4名调整为1至5名。浙江海正药业股份有限公司将于2026年9月10日召开2026年第三次临时股东会，会议采取现场与网络投票相结合方式，网络投票通过上海证券交易所系统进行。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090600000558.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0060","BK0188","BK0028","600267","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664805200","title":"股市必读：海正药业新发布《浙江海正药业股份有限公司2026年第三次临时股东会资料》","url":"https://stock-news.laohu8.com/highlight/detail?id=2664805200","media":"证券之星","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664805200?lang=zh_cn&edition=full","pubTime":"2026-09-04 01:25","pubTimestamp":1788456312,"startTime":"0","endTime":"0","summary":"公司公告汇总浙江海正药业股份有限公司2026年第三次临时股东会资料浙江海正药业股份有限公司拟修订《公司章程》部分条款，将公司高级副总裁职数由1至4名调整为1至5名。浙江海正药业股份有限公司关于召开2026年第三次临时股东会的提示性公告浙江海正药业股份有限公司将于2026年9月10日召开2026年第三次临时股东会，会议采取现场与网络投票相结合方式，网络投票通过上海证券交易所系统进行。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090400001975.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0060","600267","BK0188","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663048853","title":"每周股票复盘：海正药业（600267）Q2净利增167.81%","url":"https://stock-news.laohu8.com/highlight/detail?id=2663048853","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663048853?lang=zh_cn&edition=full","pubTime":"2026-08-30 05:00","pubTimestamp":1788037240,"startTime":"0","endTime":"0","summary":"截至2026年8月28日收盘，海正药业报收于12.2元，较上周的13.08元下跌6.73%。本周，海正药业8月24日盘中最高价报13.09元。股本股东变化截至2026年6月30日，海正药业股东户数为4.88万户，较3月31日增加1153户，增幅2.42%。第二季度单季营收20.85亿元，同比下降20.37%；单季归母净利润2.81亿元，同比上升167.81%；单季扣非净利润2.77亿元，同比上升99.55%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026083000001510.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0060","600267","BK0239","BK0028","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662340751","title":"图解海正药业中报：第二季度单季净利润同比增长167.81%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662340751","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662340751?lang=zh_cn&edition=full","pubTime":"2026-08-26 02:20","pubTimestamp":1787682018,"startTime":"0","endTime":"0","summary":"证券之星消息，海正药业2026年中报显示，上半年度公司主营收入44.75亿元，同比下降14.76%；归母净利润6.36亿元，同比上升112.82%；扣非净利润5.13亿元，同比上升59.78%；其中2026年第二季度，公司单季度主营收入20.85亿元，同比下降20.37%；单季度归母净利润2.81亿元，同比上升167.81%；单季度扣非净利润2.77亿元，同比上升99.55%；负债率31.84%，投资收益1.76亿元，财务费用3133.85万元，毛利率55.58%。财报数据概要请见下图:本文数据来源于海正药业2026年中报，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082600005125.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600267"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662737202","title":"海正药业：公司将于9月3日召开2026年半年度业绩说明会","url":"https://stock-news.laohu8.com/highlight/detail?id=2662737202","media":"证券日报 ","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662737202?lang=zh_cn&edition=full","pubTime":"2026-08-25 20:18","pubTimestamp":1787660280,"startTime":"0","endTime":"0","summary":"8月25日，海正药业发布公告称，公司2026年半年度业绩说明会定于2026年9月3日15：30-16：30在同花顺路演平台召开。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2026-08-25/doc-inippvun5512987.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2026-08-25/doc-inippvun5512987.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0060","600267","BK0188","BK0239","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662738151","title":"海正药业：上半年净利润同比增长112.82%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662738151","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662738151?lang=zh_cn&edition=full","pubTime":"2026-08-25 17:48","pubTimestamp":1787651292,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK0060","600267","BK0239","BK0028","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661221137","title":"8月24日海正药业跌7.80%，大成丰享回报混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2661221137","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661221137?lang=zh_cn&edition=full","pubTime":"2026-08-24 16:27","pubTimestamp":1787560038,"startTime":"0","endTime":"0","summary":"证券之星消息，8月24日海正药业跌7.80%，收盘报12.06元，换手率5.5%，成交量64.88万手，成交额7.99亿元。重仓海正药业的公募基金请见下表：根据2026基金半年报公募基金重仓股数据，重仓该股的公募基金共7家，其中持有数量最多的公募基金为大成基金的大成丰享回报混合A。大成丰享回报混合A的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082400021669.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0060","600267","BK0188","BK0028","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661211556","title":"每周股票复盘：海正药业（600267）担保逾期已解除","url":"https://stock-news.laohu8.com/highlight/detail?id=2661211556","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661211556?lang=zh_cn&edition=full","pubTime":"2026-08-23 01:17","pubTimestamp":1787419029,"startTime":"0","endTime":"0","summary":"截至2026年8月21日收盘，海正药业报收于13.08元，较上周的14.18元下跌7.76%。本周，海正药业8月17日盘中最高价报14.75元。海正药业当前最新总市值154.38亿元，在化学制药板块市值排名29/149，在两市A股市值排名1236/5210。此前因赞生药业未能按时偿还贷款利息180.65万元，导致公司担保范围内对应利息逾期金额72.26万元。公司已于2026年7月11日披露担保逾期公告。近日，赞生药业已偿还全部逾期利息，相关逾期担保事项已解除。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082300000101.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0188","BK0060","BK0028","600267"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661626556","title":"8月21日海正药业跌6.70%，大成丰享回报混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2661626556","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661626556?lang=zh_cn&edition=full","pubTime":"2026-08-21 16:38","pubTimestamp":1787301517,"startTime":"0","endTime":"0","summary":"证券之星消息，8月21日海正药业跌6.70%，收盘报13.08元，换手率6.08%，成交量71.8万手，成交额9.52亿元。重仓海正药业的公募基金请见下表：根据2026基金半年报公募基金重仓股数据，重仓该股的公募基金共7家，其中持有数量最多的公募基金为大成基金的大成丰享回报混合A。大成丰享回报混合A的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082100029473.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600267","BK0028","BK0188","BK0239","BK0060"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658609922","title":"异动快报：海正药业（600267）8月10日9点41分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2658609922","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658609922?lang=zh_cn&edition=full","pubTime":"2026-08-10 09:45","pubTimestamp":1786326327,"startTime":"0","endTime":"0","summary":"证券之星8月10日盘中消息，9点41分海正药业（600267）触及涨停板。其所属行业化学制药目前上涨。领涨股为哈药股份。该股为医药商业，PD-1抑制剂，阿尔茨海默病概念热股，当日医药商业概念上涨2.04%，PD-1抑制剂概念上涨1.71%，阿尔茨海默病概念上涨1.39%。8月7日的资金流向数据方面，主力资金净流入1.88亿元，占总成交额25.71%，游资资金净流出8257.65万元，占总成交额11.28%，散户资金净流出1.06亿元，占总成交额14.43%。近5日资金流向一览见下表：海正药业主要指标及行业内排名如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081000003927.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0060","BK0239","600267","BK0188","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658556673","title":"每周股票复盘：海正药业（600267）5产品拟中选集采","url":"https://stock-news.laohu8.com/highlight/detail?id=2658556673","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658556673?lang=zh_cn&edition=full","pubTime":"2026-08-09 01:10","pubTimestamp":1786209018,"startTime":"0","endTime":"0","summary":"截至2026年8月7日收盘，海正药业报收于13.11元，较上周的11.58元上涨13.21%。本周，海正药业8月7日盘中最高价报13.11元，股价触及近一年最高点。海正药业当前最新总市值154.73亿元，在化学制药板块市值排名30/149，在两市A股市值排名1247/5205。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080900000063.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600267","BK0188","BK0060","BK0028","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657769615","title":"8月7日海正药业涨9.98%，大成丰享回报混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2657769615","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657769615?lang=zh_cn&edition=full","pubTime":"2026-08-07 16:36","pubTimestamp":1786091778,"startTime":"0","endTime":"0","summary":"证券之星消息，8月7日海正药业涨9.98%创60日新高，收盘报13.11元，换手率4.82%，成交量56.91万手，成交额7.32亿元。重仓海正药业的公募基金请见下表：根据2026基金半年报公募基金重仓股数据，重仓该股的公募基金共7家，其中持有数量最多的公募基金为大成基金的大成丰享回报混合A。大成丰享回报混合A的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080700027857.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0060","BK0239","600267","BK0188","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656535054","title":"8月4日海正药业涨6.39%，大成丰享回报混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2656535054","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2656535054?lang=zh_cn&edition=full","pubTime":"2026-08-04 16:26","pubTimestamp":1785831983,"startTime":"0","endTime":"0","summary":"证券之星消息，8月4日海正药业涨6.39%，收盘报12.15元，换手率5.42%，成交量63.96万手，成交额7.67亿元。重仓海正药业的公募基金请见下表：根据2026基金半年报公募基金重仓股数据，重仓该股的公募基金共7家，其中持有数量最多的公募基金为大成基金的大成丰享回报混合A。大成丰享回报混合A的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080400027203.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600267","BK0188","BK0239","BK0060","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656232990","title":"海正药业(600267.SH):他克莫司胶囊等5个产品拟中选集中带量采购","url":"https://stock-news.laohu8.com/highlight/detail?id=2656232990","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2656232990?lang=zh_cn&edition=full","pubTime":"2026-08-03 15:44","pubTimestamp":1785743076,"startTime":"0","endTime":"0","summary":"智通财经APP讯，海正药业 发布公告，2026年7月31日，公司及全资子公司瀚晖制药有限公司参加了联合采购办公室组织的第十二批国家组织药品集中带量采购的投标工作，根据联采办当晚发布的《第12批国家组织药品集中带量采购拟中选结果公示》，公司及全资子公司瀚晖制药符合本次集中带量采购范围的5个产品拟中选本次集中带量采购。上述拟中选产品2025年度销售额合计4.26亿元，占公司2025年度营业收入的比例约为4.04%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1475223.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0060","600267","BK0188","BK0239","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653700110","title":"海正药业(600267.SH)子公司制剂产品磷酸氟达拉滨注射液获得美国FDA批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2653700110","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2653700110?lang=zh_cn&edition=full","pubTime":"2026-07-24 16:53","pubTimestamp":1784883217,"startTime":"0","endTime":"0","summary":"智通财经APP讯，海正药业(600267.SH)发布公告，近日，公司全资子公司海正药业(杭州)有限公司(简称“海正杭州公司”)收到美国食品药品监督管理局(简称“美国FDA”)的通知，海正杭州公司向美国FDA申报的磷酸氟达拉滨注射液的新药简略申请(ANDA，即美国仿制药申请)已获得批准，意味着海正杭州公司可以在美国市场销售该产品。据悉，磷酸氟达拉滨注射液是一种核苷代谢抑制剂，适应症为：作为联合治疗方案的组成药物，用于治疗成人B细胞慢性淋巴细胞白血病(CLL);用于对既往接受至少1种含烷化剂的治疗方案治疗无效，或在治疗过程中出现疾病进展的成人B细胞慢性淋巴细胞白血病患者。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1471931.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["600267","BK0239","BK0060","BK4588","BK0028","BK0188","BK4585","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653795102","title":"海正药业：三箭齐发+战略瘦身，老牌药企重塑增长内核","url":"https://stock-news.laohu8.com/highlight/detail?id=2653795102","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2653795102?lang=zh_cn&edition=full","pubTime":"2026-07-21 18:30","pubTimestamp":1784629801,"startTime":"0","endTime":"0","summary":"亮眼的数据表现并非短期红利，而是海正药业深耕制药主业，创新药、原料药、宠物药三大板块协同发力，叠加公司主动战略瘦身、剥离低效资产的双重成果，这家老牌药企悄然完成转型升级，正式迈入发展新阶段。2026年上半年，海正药业对外转让浙江省医药工业有限公司100%股权，进一步聚焦主业。2026年上半年，海正药业预计实现扣非归母净利润4.9亿元至5.3亿元，同比增长52.54%至64.99%。海正药业此次主动瘦身，本质是国资药企回归产业本源的理性选择。","market":"hk","thumbnail":" http://caiji.3g.cnfol.com/colect/202607/21/20260721977262.jpg","type":0,"news_type":0,"thumbnails":[" http://caiji.3g.cnfol.com/colect/202607/21/20260721977262.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/ggzixun/20260721/32313949.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK0239","BK0060","BK0188","600267","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652500211","title":"海正药业（600267）披露与艾缇亚签署产品独家授权许可及合作协议，7月20日股价上涨9.98%","url":"https://stock-news.laohu8.com/highlight/detail?id=2652500211","media":"证券之星","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2652500211?lang=zh_cn&edition=full","pubTime":"2026-07-20 22:15","pubTimestamp":1784556922,"startTime":"0","endTime":"0","summary":"截至2026年7月20日收盘，海正药业报收于12.45元，较前一交易日上涨9.98%，最新总市值为146.94亿元。该股当日开盘11.4元，最高12.45元，最低11.36元，成交额达12.28亿元，换手率为8.52%。近日，海正药业披露《2026年第二次临时股东会决议公告》。公告显示，公司于2026年7月20日召开2026年第二次临时股东会，审议通过《关于公司与艾缇亚（上海）制药有限公司签署产品独家授权许可及合作协议的议案》。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072000039486.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0060","BK0188","BK0239","600267","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652528219","title":"海正药业与艾缇亚达成合作","url":"https://stock-news.laohu8.com/highlight/detail?id=2652528219","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2652528219?lang=zh_cn&edition=full","pubTime":"2026-07-20 21:46","pubTimestamp":1784555160,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK0028","BK0060","600267","BK0188","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652625266","title":"异动快报：海正药业（600267）7月20日9点53分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2652625266","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2652625266?lang=zh_cn&edition=full","pubTime":"2026-07-20 09:55","pubTimestamp":1784512535,"startTime":"0","endTime":"0","summary":"证券之星7月20日盘中消息，9点53分海正药业（600267）触及涨停板。其所属行业化学制药目前上涨。领涨股为益方生物。该股为PD-1抑制剂，浙江国企改革，国企改革概念热股，当日PD-1抑制剂概念上涨2.41%，浙江国企改革概念上涨1.54%，国企改革概念上涨1.38%。7月17日的资金流向数据方面，主力资金净流出6899.56万元，占总成交额11.1%，游资资金净流出1898.11万元，占总成交额3.05%，散户资金净流入8797.67万元，占总成交额14.15%。近5日资金流向一览见下表：海正药业主要指标及行业内排名如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072000005786.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0188","BK0060","BK0239","600267"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652130237","title":"每周股票复盘：海正药业（600267）获来特莫韦片注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2652130237","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2652130237?lang=zh_cn&edition=full","pubTime":"2026-07-19 01:29","pubTimestamp":1784395747,"startTime":"0","endTime":"0","summary":"截至2026年7月17日收盘，海正药业报收于11.32元，较上周的10.77元上涨5.11%。本周，海正药业7月15日盘中最高价报12.27元。来自公司公告汇总：海正药业将于2026年7月20日召开临时股东会审议TISA-818合作事项。浙江海正药业股份有限公司收到国家药监局核准签发的来特莫韦片《药品注册证书》，批准注册为化学药品4类，视同通过一致性评价。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071900000237.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","600267","BK0028","BK0188","BK0060"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1788811698461,"stockEarnings":[{"period":"1week","weight":-0.0276},{"period":"1month","weight":-0.1144},{"period":"3month","weight":0.2497},{"period":"6month","weight":0.1348},{"period":"1year","weight":0.1145},{"period":"ytd","weight":0.1979}],"compareEarnings":[{"period":"1week","weight":-0.0134},{"period":"1month","weight":-0.0019},{"period":"3month","weight":-0.0193},{"period":"6month","weight":-0.0486},{"period":"1year","weight":0.0315},{"period":"ytd","weight":-0.0091}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"浙江海正药业股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"48826人(较上一季度增加2.42%)","perCapita":"24173股","listingDate":"2000-07-25","address":"浙江省台州市椒江区外沙路46号","registeredCapital":"118027万元","survey":" 浙江海正药业股份有限公司的主营业务是药品的研发、生产和销售。公司的主要产品是海博麦布片（赛斯美）、注射用哌拉西林钠他唑巴坦钠（特治星）、盐酸米诺环素胶囊（玫满）、茚达特罗格隆溴铵吸入粉雾剂（杰润）、注射用丝裂霉素、瑞舒伐他汀钙片（海舒严）、注射用亚胺培南西司他丁钠（俊特）、米尔贝肟吡喹酮片（海乐妙）、丁二磺酸腺苷蛋氨酸肠溶片（喜美欣）、英夫马芬净。","listedPrice":11.83},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"海正药业(600267)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供海正药业(600267)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"海正药业,600267,海正药业股票,海正药业股票老虎,海正药业股票老虎国际,海正药业行情,海正药业股票行情,海正药业股价,海正药业股市,海正药业股票价格,海正药业股票交易,海正药业股票购买,海正药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"海正药业(600267)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供海正药业(600267)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}